Table 1 The effects of the GRSLC on CRC and the GRSCRC on LC
Exposure | Outcome | OR (95% CI) | P value | Exposure | Outcome | OR (95% CI) | P value |
|---|---|---|---|---|---|---|---|
Overall LC | Overall CRC | 1.0026 (1.0012–1.0039) | 0.0002 | Overall CRC | Overall LC | 1.0074 (0.9112–1.1137) | 0.89 |
Colon cancer | 1.0014 (1.0005–1.0023) | 0.0028 | LUSC | 1.1206 (0.9096–1.3806) | 0.28 | ||
Rectal cancer | 1.5979 (1.2695–2.0113) | 6.53E-05 | LUAD | 1.0634 (0.8991–1.2577) | 0.47 | ||
LUSC | Overall CRC | 1.0017 (1.0008–1.0026) | 0.0002 | Colon cancer | Overall LC | 1.0080 (0.8989–1.1302) | 0.89 |
Colon cancer | 1.0008 (1.0002–1.0014) | 0.01 | LUSC | 1.2085 (0.9525–1.5332) | 0.12 | ||
Rectal cancer | 1.3719 (1.1654–1.6150) | 0.0001 | LUAD | 1.1274 (0.9309–1.3652) | 0.22 | ||
LUAD | Overall CRC | 0.9993 (0.9979–1.0007) | 0.3 | Rectal cancer | Overall LC | 1.0508 (0.9214–1.1984) | 0.46 |
Colon cancer | 1.0004 (0.9994–1.0013) | 0.47 | LUSC | 1.1469 (0.8727–1.5072) | 0.33 | ||
Rectal cancer | 0.8882 (0.7156–1.1026) | 0.28 | LUAD | 1.0617 (0.8522–1.3227) | 0.59 |